Georgetown University
Raymond Scott Turner, MD, PhD
Site PI
Dr. Raymod Scott Turner is a tenured Professor in the Department of Neurology and Director of the Memory Disorders Program at Georgetown University. He received his doctorate and medical degrees from Emory University, followed by an internship in Internal Medicine, residency in Neurology, and a Howard Hughes Medical Institute-sponsored fellowship in behavioral and cognitive neurology - all at the University of Pennsylvania. Prior to moving to Georgetown, he was Chief of the Neurology Service at the VA Ann Arbor Healthcare System and tenured Associate Professor and Associate Chair in the Department of Neurology, University of Michigan. He is board-certified in psychiatry and neurology. Dr. Turner directs the Memory Disorders Program at the MedStar Georgetown University Hospital. His research is focused on developing new treatments and biomarkers for neurodegenerative dementias of aging, particularly Mild Cognitive Impairment and dementia due to Alzheimer’s disease. He has published over 100 peer-reviewed papers, reviews, and book chapters. Dr. Turner is on the steering committees of the Alzheimer’s Disease Cooperative Study (ADCS) and the Alzheimer’s Therapeutic Research Institute (ATRI), and is a Site PI for the NIH-funded Alzheimer’s Clinical Trials Consortium (ACTC). He is also a Site PI for several multi-center, randomized, placebo-controlled clinical studies.
Brigid Reynolds, MSN, ANP-BC
Site Co-PI
Brigid Reynolds joined the Memory Disorders Program in 2001. She received her Master of Science in Nursing from the Catholic University of America and a Bachelor of Science in Nursing from Emory University. Brigid is certified by the American Academy of Nurse Practitioners. Prior to joining the Memory Disorders Program, Brigid’s career focused on home care, primary care, and case management for elderly patients. Presently she is on Faculty at Georgetown University where she specializes in evaluating and treating patients with memory problems and is a Research Investigator conducting clinical trials of potential new treatments for Alzheimer’s disease and related disorders.
